Mankind`s Generic Prazosin Hydrochloride Receives Approval in the U.S.
Appco's Generic Prazosin Hydrochloride Receives Approval in the U.S.
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Food and Drug Administration’s (“FDA”) approval of the Company’s prior approval supplement application (“PAS”).
BAUDETTE, Minn.--(BUSINESS WIRE)--ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced the launch of Prazosin HCl Capsules USP, 1mg and 2mg, following the U.S. Food and Drug Administration’s (“FDA”) approval of the Company’s prior approval supplement application (“PAS”).
The Therapeutic Goods Administration (TGA) is advising health professionals and consumers that there is an ongoing shortage of medicines containing olmesartan or prazosin as the sole active ingredient.
Novitium Pharma's Generic Prazosin Hydrochloride Receives Approval in US
IDT Australia release on FDA nod for 23 generics begs the question: Where`s the beef?